Does RIBOCICLIB Cause Metastases to lung? 649 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 649 reports of Metastases to lung have been filed in association with RIBOCICLIB (KISQALI). This represents 2.3% of all adverse event reports for RIBOCICLIB.
649
Reports of Metastases to lung with RIBOCICLIB
2.3%
of all RIBOCICLIB reports
112
Deaths
144
Hospitalizations
How Dangerous Is Metastases to lung From RIBOCICLIB?
Of the 649 reports, 112 (17.3%) resulted in death, 144 (22.2%) required hospitalization, and 38 (5.9%) were considered life-threatening.
Is Metastases to lung Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 649 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Metastases to lung?
LETROZOLE (703)
CAPECITABINE (616)
BEVACIZUMAB (578)
PACLITAXEL (563)
FULVESTRANT (560)
EVEROLIMUS (522)
TRASTUZUMAB (458)
DOCETAXEL (415)
FLUOROURACIL (375)
CARBOPLATIN (369)
Which RIBOCICLIB Alternatives Have Lower Metastases to lung Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN